We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




Neuromodulation Platform Receives CE Marking for Use with 3-Tesla MRI

By MedImaging International staff writers
Posted on 18 Feb 2015
Print article
Image: Senza SCS System Components (Photo courtesy of Nevro).
Image: Senza SCS System Components (Photo courtesy of Nevro).
An implantable Spinal Cord Simulation (SCS) platform intended for the treatment of chronic pain has received CE marking (Conformité Européenne) approval for expanded MR-conditional (Magnetic Resonance) labeling.

The CE marking will provide patients already receiving HF10 (High-Frequency, 10 kHz) SCS treatment with access to Magnetic Resonance Imaging (MRI) scans.

All versions of the 5-year-old SCS system, produced by Nevro (Menlo Park, CA, USA), can now be marketed in Europe and Australia, and anywhere the system is sold, for use with 1.5 Tesla and 3.0 Tesla MRI scans of the head and extremities. This is the first implantable SCS system to receive 3-Tesla compatibility.

The Senza SCS system delivers electrical pulses by means of small electrodes implanted near the spinal cord and connected to a battery-powered generator also implanted under the skin.

According to Michael DeMane, Chairman and Chief Executive Officer of Nevro, “We are pleased to offer even more imaging options for our patients. Nevro is a company that is continually looking to advance the SCS space, and this expanded MR-conditional labeling highlights our ongoing commitment to innovation.”

Related Links:

Nevro  


Gold Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
MRI System
uMR 588
Compact C-Arm with FPD
Arcovis DRF-C R21
Laptop Ultrasound Scanner
PL-3018

Print article

Channels

Radiography

view channel
:	Image: The AI model could be a valuable adjunct to human radiologists in breast cancer diagnoses and risk prediction (Photo courtesy of 123RF)

AI Model Predicts 5-Year Breast Cancer Risk from Mammograms

Approximately 13% of U.S. women, or one in every eight, are predicted to develop invasive breast cancer over their lifetime, with 1 in 39 women (3%) succumbing to the illness, according to the American... Read more

Nuclear Medicine

view channel
Image: The AI system uses scintigraphy imaging for early diagnosis of cardiac amyloidosis (Photo courtesy of 123RF)

AI System Automatically and Reliably Detects Cardiac Amyloidosis Using Scintigraphy Imaging

Cardiac amyloidosis, a condition characterized by the buildup of abnormal protein deposits (amyloids) in the heart muscle, severely affects heart function and can lead to heart failure or death without... Read more

General/Advanced Imaging

view channel
Image: The CIARTIC Move self-driving mobile C-arm has received FDA clearance (Photo courtesy of Siemens)

Self-Driving Mobile C-Arm Reduces Imaging Time during Surgery

Intraoperative imaging faces significant challenges due to staff shortages and the high demands placed on surgical teams in the operating room (OR). A common challenge during many OR procedures is the... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more

Industry News

view channel
Image: Samsung Medison CEO Mr. Yongkwan Kim and Bracco Imaging CEO Dr. Fulvio Renoldi Bracco endorsed a MoU agreement (Photo courtesy of Bracco Group)

Samsung and Bracco Enter Into New Diagnostic Ultrasound Technology Agreement

Samsung Medison (Seoul, South Korea) and Bracco Imaging (Milan, Italy) have entered into a Memorandum of Understanding (MoU) agreement to pioneer a new area for diagnostic ultrasound devices and contrast agents.... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.